Proteolix's Series B Round

Proteolix raised a round of funding on May 11, 2006.

Proteolix is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target certain cancers by introducing proteasome inhibition and thereby disrupt…

Articles about Proteolix's Series B Round: